A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Hillchol® (BBV131)to Shanchol™ Along With Lot-to-lot Consistency of Hillchol®(BBV131).
Clinical trial NCT05507229 · UNKNOWN
Trial details
- NCT number
- NCT05507229
- Sponsor
- Bharat Biotech International Limited
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-22
- Primary completion
- 2022-07-30
- Enrollment
- 1800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.